• Cisplatin (CDDP): Protocols, Troubleshooting & Advanced Canc

  2026-07-21

  Cisplatin (CDDP) from APExBIO is a gold-standard DNA crosslinking agent, empowering researchers with robust tumor growth inhibition and apoptosis assay workflows. This guide translates cutting-edge findings into actionable protocols, troubleshooting insights, and comparative advantages for advanced oncology research.

• miRNA–mRNA Modules Drive Juvenile Hormone Synthesis in Insec

  2026-07-21

  This study uncovers how coordinated miRNA–mRNA interactions enhance juvenile hormone (JH) biosynthesis during vitellogenesis in adult locusts. The findings reveal a post-transcriptional regulatory mechanism crucial for egg production, advancing our understanding of hormone-regulated development in insects.

• Human Gastrin I Peptide: Advanced GI Physiology & Organoid R

  2026-07-20

  Unlock mechanistic insight into gastric acid secretion and gastrointestinal physiology using human Gastrin I peptide. This article delivers actionable workflows, troubleshooting strategies, and benchmarking for organoid and cell-based models—empowering translational research in acid-related disorders and pharmacokinetics.

• Necrostatin-1: RIP1 Kinase Inhibitor for Advanced Necroptosi

  2026-07-20

  Necrostatin-1 stands apart as a potent and selective RIP1 kinase inhibitor, enabling precise dissection of necroptosis in both basic and translational research. With literature-backed protocols and troubleshooting insights, it empowers reliable exploration of cell death pathways in inflammation and acute injury models.

• ATRX Deficiency Sensitizes Glioma to RTK and PDGFR Inhibitor

  2026-07-19

  The referenced study demonstrates that high-grade glioma cells lacking ATRX are markedly more sensitive to multi-targeted receptor tyrosine kinase (RTK) and PDGFR inhibitors. These findings highlight the importance of considering ATRX mutation status in designing therapeutic strategies and interpreting clinical trial outcomes in glioma research.

• Refining In Vitro Drug Response Metrics in Cancer Research

  2026-07-18

  Schwartz’s dissertation critically re-examines how in vitro assays measure drug-induced effects in cancer, distinguishing between proliferative arrest and cell death. The work proposes a more nuanced, dual-metric approach that addresses limitations of traditional single-metric readouts, aiding more precise evaluation of anti-cancer agents.

• CDK9 Inhibitor (A3294): Technical Use and Workflow Guidance

  2026-07-17

  CDK9 inhibitor (A3294) provides selective inhibition of cyclin dependent kinase 9, enabling precise modulation of transcription elongation and HIV-1 propagation in cellular assays. It should not be used for broad-spectrum CDK inhibition or for protocols that require prolonged storage of working solutions, as its selectivity and stability are optimized for short-term applications.

• Applied Workflows with the 7-AAD Cell Viability Assay Kit

  2026-07-17

  The 7-AAD Cell Viability Assay Kit from APExBIO delivers precise, multiplexable detection of necrosis and apoptosis, making it a benchmark tool for advanced CAR-T engineering and translational immunotherapy. Discover workflow optimizations, troubleshooting strategies, and unique comparative advantages that streamline high-fidelity cell viability analytics in next-generation research.

• Strategic Deployment of CCK-8 for Translational Cardiac Repa

  2026-07-16

  This article explores how Cell Counting Kit-8 (CCK-8) empowers translational researchers to quantitatively assess cellular viability and cytotoxicity in cutting-edge cardiac repair models. By bridging mechanistic insight into myocardial patch integration with actionable guidance for robust cell-based assay design, we highlight CCK-8’s pivotal role in accelerating preclinical validation for next-generation biomaterials, such as injectable conductive hydrogels targeting myocardial infarction.

• Gastrin I: Precision Tools for Gastric Acid Secretion Pathwa

  2026-07-16

  Human Gastrin I peptide from APExBIO empowers researchers to model gastric acid secretion and CCK2 receptor signaling in both traditional and organoid-based systems. This guide translates cutting-edge reference protocols into actionable workflows for gastrointestinal disorder research and advanced pharmacokinetic studies.

• miRNA–mRNA Control of Juvenile Hormone in Insect Reproductio

  2026-07-15

  This study elucidates how coordinated miRNA–mRNA modules regulate juvenile hormone biosynthesis, driving vitellogenesis and egg production in locusts. The findings clarify a post-transcriptional mechanism essential for reproductive endocrinology and suggest new molecular targets for insect population management.

• miRNA–mRNA Regulation of Juvenile Hormone Drives Egg Product

  2026-07-15

  Li et al. reveal that coordinated miRNA–mRNA modules upregulate juvenile hormone biosynthesis in adult locusts, enabling vitellogenesis and egg production. This work clarifies a key post-transcriptional mechanism in insect reproductive endocrinology, with implications for both fundamental research and targeted insect control strategies.

• A40926: Dalbavancin Precursor & Glycopeptide Antibiotic Benc

  2026-07-14

  A40926 is a validated glycopeptide antibiotic and direct dalbavancin precursor, exhibiting potent activity against Gram-positive bacteria and Neisseria gonorrhoeae. It serves as a gold-standard tool for in vitro antibacterial assays and advanced research on resistant pathogens, supported by robust regulatory and biosynthetic characterization.

• Tamsulosin in Urological Research: Protocols, Performance, a

  2026-07-14

  Tamsulosin’s selectivity for α₁A-adrenergic receptors has transformed experimental models of urinary flow and postoperative urinary retention. This article details stepwise workflows, protocol refinements, and troubleshooting tactics—grounded in the latest meta-analytic evidence—to maximize reproducibility and translational impact.

• GW 4869 Hydrochloride Hydrate: Exosome Release Inhibition in

  2026-07-13

  GW 4869 hydrochloride hydrate is a selective inhibitor of exosome biogenesis via noncompetitive inhibition of neutral sphingomyelinase. It is widely used to dissect vesicle-mediated cell signaling in disease models, including lupus nephritis, demonstrating robust attenuation of endothelial injury by suppressing ceramide-driven exosome release.

14601 records 1/974 page Next 12345 下5页 Last page